Clinton Bybee, 10% Owner of Lyell Immunopharma LYEL, has filed 8 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $17.5M. The latest trade was on 03/06.

CB

CB

Clinton Bybee

10% Owner

Company

Lyell Immunopharma LYEL

First filing

23/09/20

Trades

30 trades

Buys / sales

8 / 0

12-month net buying

$17.5M

Last trade

03/06

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Lyell ImmunopharmaLYEL	Open-market buy	03/06	03/09	488,090 sh	$25.61	$12,499,984.9	+52.0%
Neumora TherapeuticsNMRA	Open-market buy	25/10/27	25/10/29	1,915,700 sh	$2.61	$4,999,977	+46.4%
Boundless BioBOLD	Open-market buy	24/04/02	24/04/04	200,000 sh2 trades	$16.00avg.	$3,200,000	+20.4%
Sana BiotechnologySANA	Open-market buy	24/02/08	24/02/12	1,818,181 sh3 trades	$5.50avg.	$9,999,995.5	+17.1%
Neumora TherapeuticsNMRA	Open-market buy	23/09/19	23/09/20	1,500,000 sh	$17.00	$25,500,000	+70.6%